{{ $DoctorName }} @if (isset(session()->get('doctor')['vCentralCode'])) {{ session()->get('doctor')['vCentralCode'] }} @endif
@if (isset(session()->get('doctor')['vCentralCode']))
Logout
@endif

{{ $ActivityTypeName }}

{{ $ActivityName }}

@csrf
@if (isset(session()->get('doctor')['vCentralCode']))
Back
@else
@endif

Survey on diagnosis and treatment of Ankylosing Spondylitis in India

Doctor’s details
@if (isset(session()->get('doctor')['vCentralCode']))
@else
@endif

Questionnaire

  1. What is the common profile of patients you typically see with Ankylosing Spondylitis?*
    2. a. Age: most common age group

    b. Gender

    c. Geographic location:

  2. In your practice, do you observe gender disparities in the prevalence or management of Ankylosing Spondylitis ? *

  3. How commonly do you encounter Ankylosing Spondylitis in your patients? *

  4. What advice do you provide to your patients with Ankylosing Spondylitis regarding lifestyle modifications? *
  5. Which stage of Ankylosing Spondylitis patients do you encounter the most? *

  6. What are the most common presenting symptoms of Ankylosing Spondylitis? *

  7. What is the most reliable test to differentiate Ankylosing Spondylitis from other similar conditions? *

  8. Which is your most preferred NSAID for the management of Ankylosing Spondylitis? *

  9. Which conditions commonly mimic Ankylosing Spondylitis in your practice? *

  10. Do you advise Muscle relaxants (MR) in the management of Ankylosing Spondylitis? *

  11. What is your drug of choice in the management of pain and inflammation in Ankylosing Spondylitis ? *

  12. For what duration do you generally prescribe the above selection? *
  13. Which is your preferred muscle relaxant/NSAID or combination for Ankylosing Spondylitis? *

  14. How do you determine the suitability of a particular NSAID or muscle relaxant for an individual patient? *

  15. How many refractory cases of Ankylosing Spondylitis do you encounter in a month? *

  16. How do you handle patients with Ankylosing Spondylitis who are refractory to conventional treatments? *
  17. How often do you recommend follow-up visits for Ankylosing Spondylitis patients? *

  18. Do you usually change the muscle relaxants during the follow-up visits? *

  19. How often do you reassess the treatment regimen for your Ankylosing Spondylitis patients? *

  20. What parameters do you monitor during the follow-up visits & how do you evaluate the effectiveness of the current treatment plan? *
  21. What are the complications of untreated Ankylosing Spondylitis? *

  22. What’s the typical timeframe for the onset of complications in untreated Ankylosing Spondylitis? *
  23. What is the average duration between the onset of symptoms & diagnosis of Ankylosing Spondylitis in your patients, mention the percentage of patients diagnosed in early stage? *
  24. What challenges do you face in ensuring regular follow up visits for Ankylosing Spondylitis patients? *
  25. Which patient populations are advised for biologics in Ankylosing Spondylitis? *

  26. Which out the following are the most common biologics preferred in the management of Ankylosing Spondylitis? *

  27. How do you ensure patient adherence to treatment? *

  28. Which barriers exist in the effective management of Ankylosing Spondylitis in your practice? *
  29. What are the common conditions that complicate the management of Ankylosing Spondylitis? *

  30. What educational initiatives do you believe are necessary to improve Ankylosing Spondylitis management? *

  31. What are the potential long-term complications of Ankylosing Spondylitis treatments you observe? *
  32. Which clinical guidelines do you follow for the management of Ankylosing Spondylitis? Do you face any challenges while implementing these guidelines practically? *
  33. What recent advancements in Ankylosing Spondylitis therapy have you integrated into your practice & how do you stay updated with these advancements? *
  34. What non-pharmacological therapies do you recommend for Ankylosing Spondylitis patients? *